19.41500 EUR
1.285
7.09%
Last update Dec 16, 5:19 PM CET
Main market
Day range
18.96000
19.63500
Previous close
18.13000
Open
18.96000
Access this stock data via API
Subscribe
Sarepta Therapeutics Inc.
19.42
1.29
7.09%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024
Total reported revenue 1.6B
Cost of revenue 272.0M
Gross profit 1.3B
Operating expense
Research & development 685.7M
Selling general and admin 475.4M
Other operating expenses
Operating income 185.9M
Non operating interest income
Income 61.2M
Expense 15.7M
Other income expense -9.1M
Pretax income 222.2M
Tax provision 21.8M
Net income 200.5M
Basic EPS 2.5
Diluted EPS 2.3
Basic average shares 81.0M
Diluted average shares 81.0M
EBITDA 276.7M
Net income from continuing op. 200.5M
Minority interests
Preferred stock dividends
Access /income_statement data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 2 hours 13 minutes

15:16
00:00
09:00
17:30
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 09:00
Main market
09:00 - 17:30
All times are displayed in the Europe/Rome timezone (CET, UTC+01:00).